20th Dec 2006 10:28
Ark Therapeutics Group PLC20 December 2006 20 December 2006 Ark Therapeutics Group plc Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6, ArkTherapeutics Group plc (LSE: AKT) ("Ark" or the "Company") would like to notifythe market that the Company's capital consists of 165,915,859 ordinary shareswith voting rights. This figure may be used by shareholders as the denominatorfor the calculations by which they will determine if they are required to notifytheir interest in, or a change to the interest in, Ark under the FSA'sDisclosure and Transparency Rules. - Ends - This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PVG.L